Save up -80% on Aclidinium
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Tudorza Pressair
|$322.61||1 inhaler (60 doses) 400mcg|
|Price with discount in nearest pharmacy. Price may vary.|
We offer free Aclidinium coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Aclidinium every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Aclidinium volume of distribution
Following IV administration, the volume of distribution is 300 L. Intravenously administered radiolabelled aclidinium bromide was administered to healthy volunteers and was extensively metabolized with 1% excreted as unchanged aclidinium. Approximately 54% to 65% of the radioactivity was excreted in urine and 20% to 33% of the dose was excreted in feces.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Aclidinium
Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
Aclidinium mechanism of action
Aclidinium is a long-acting, competitive, and reversible anticholinergic drug that is specific for the acetylcholine muscarinic receptors. It binds to all 5 muscarinic receptor subtypes to a similar affinity. Aclidinium’s effects on the airways are mediated through the M3 receptor at the smooth muscle to cause bronchodilation. Prevention of acetylcholine-induced bronchoconstriction effects was dose-dependent and lasted longer than 24 hours.
Dosage forms of Aclidinium
|Tudorza Pressair||400mcg||1 inhaler (30 doses)||$157.80|
|Tudorza Pressair||400mcg||3 inhalers (30 doses)||$486.94|
|Tudorza Pressair||400mcg||1 inhaler (60 doses)||$313.27|
|Tudorza Pressair||400mcg||30 inhalers (60 doses)||$9,343|
Astrazeneca Canada Inc
Humans and other mammals
Indication of Aclidinium
Aclidinium bromide inhalation powder is indicated for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Toxicity of Aclidinium
Most common adverse reactions ( 3% incidence and greater than placebo) are headache, nasopharyngitis and cough.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Aclidinium on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.